Figure 2.
Overall survival (OS; A) and duration of treatment (DOT; B) in patients treated with immunotherapy in combination with chemotherapy (chemo-IT) (n=58).
Overall survival (OS; A) and duration of treatment (DOT; B) in patients treated with immunotherapy in combination with chemotherapy (chemo-IT) (n=58).